BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15690967)

  • 1. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
    Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
    Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (
    Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
    Lalouschek W; Lang W; Müllner M;
    Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.
    Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
    Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke - ANAFIE Registry.
    Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K;
    Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort.
    Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E
    JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.
    Palomäki A; Kiviniemi T; Hartikainen JE; Mustonen P; Ylitalo A; Nuotio I; Hartikainen P; Jaakkola J; Luite R; Airaksinen KE
    Clin Cardiol; 2016 Aug; 39(8):471-6. PubMed ID: 27240121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation.
    Gumbinger C; Holstein T; Stock C; Rizos T; Horstmann S; Veltkamp R
    Eur Neurol; 2015; 73(3-4):184-91. PubMed ID: 25633474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ninety-Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke.
    Wilson G; Sharma M; Eagles D; Nemnom MJ; Sivilotti MLA; Émond M; Stiell IG; Stotts G; Lee J; Worster A; Morris J; Cheung KW; Jin AY; Oczkowski WJ; Sahlas DJ; Murray HE; Mackey A; Verreault S; Camden MC; Yip S; Teal P; Gladstone DJ; Boulos MI; Chagnon N; Shouldice E; Atzema C; Slaoui T; Teitlebaum J; Wells GA; Nath A; Perry JJ
    J Am Heart Assoc; 2023 Apr; 12(8):e026681. PubMed ID: 37026540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
    RAF and RENO-EXTEND Investigators*
    Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.
    Palomäki A; Mustonen P; Hartikainen JE; Nuotio I; Kiviniemi T; Ylitalo A; Hartikainen P; Airaksinen KE
    Eur J Neurol; 2016 Jan; 23(1):133-9. PubMed ID: 26263442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
    van Walraven C; Hart RG; Connolly S; Austin PC; Mant J; Hobbs FD; Koudstaal PJ; Petersen P; Perez-Gomez F; Knottnerus JA; Boode B; Ezekowitz MD; Singer DE
    Stroke; 2009 Apr; 40(4):1410-6. PubMed ID: 19182090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation.
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; Conghaile Aó; Canavan M; O'Donnell MJ;
    Stroke; 2014 Dec; 45(12):3637-42. PubMed ID: 25378422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.